PATIENTS TO BE INCLUDED IN CLINICAL TRIALS ASSESSING THE SAFETY AND EFFICACY OF NEW CHEMICAL ENTITIES AIMING AT THE TREATMENT OF SARCOPENIA

被引：0
|
作者：
Rosa, M. M. [1 ,2 ]
机构：
[1] Univ Lisbon, Fac Med, Lab Farmacol Clin & Terapeut, Lisbon, Portugal
[2] CHULN, Neurol Dept, Lisbon, Portugal
来源：
OSTEOPOROSIS INTERNATIONAL | 2021年 / 32卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ESCEO3
引用
收藏
页码：S58 / S59
页数：2
相关论文
共 50 条
  • [1] PRIMARY AND SECONDARY ENDPOINTS FOR CLINICAL TRIALS ASSESSING THE SAFETY AND EFFICACY OF NEW CHEMICAL ENTITIES AIMING AT THE TREATMENT OF SARCOPENIA
    Laslop, A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S59 - S59
  • [2] Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trials
    Leppik, Ilo E.
    Wechsler, Robert T.
    Williams, Betsy
    Yang, Haichen
    Zhou, Sharon
    Laurenza, Antonio
    [J]. EPILEPSY RESEARCH, 2015, 110 : 216 - 220
  • [3] Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults
    Reginster, Jean-Yves
    Beaudart, Charlotte
    Al-Daghri, Nasser
    Avouac, Bernard
    Bauer, Juergen
    Bere, Nathalie
    Bruyere, Olivier
    Cerreta, Francesca
    Cesari, Matteo
    Miguel Rosa, Mario
    Cooper, Cyrus
    Jentoft, Alfonso J. Cruz
    Dennison, Elaine
    Geerinck, Anton
    Gielen, Evelien
    Landi, Francesco
    Laslop, Andrea
    Maggi, Stefania
    Prieto Yerro, Maria Concepcin
    Rizzoli, Rene
    Sundseth, Hildrun
    Sieber, Cornel
    Trombetti, Andrea
    Vellas, Bruno
    Veronese, Nicola
    Visser, Marjolein
    Vlaskovska, Mila
    Fielding, Roger A.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (01) : 3 - 17
  • [4] Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults
    Jean-Yves Reginster
    Charlotte Beaudart
    Nasser Al-Daghri
    Bernard Avouac
    Jürgen Bauer
    Nathalie Bere
    Olivier Bruyère
    Francesca Cerreta
    Matteo Cesari
    Mario Miguel Rosa
    Cyrus Cooper
    Alfonso J. Cruz Jentoft
    Elaine Dennison
    Anton Geerinck
    Evelien Gielen
    Francesco Landi
    Andrea Laslop
    Stefania Maggi
    María Concepción Prieto Yerro
    René Rizzoli
    Hildrun Sundseth
    Cornel Sieber
    Andrea Trombetti
    Bruno Vellas
    Nicola Veronese
    Marjolein Visser
    Mila Vlaskovska
    Roger A. Fielding
    [J]. Aging Clinical and Experimental Research, 2021, 33 : 3 - 17
  • [5] Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities
    Cornel Pater
    [J]. Current Controlled Trials in Cardiovascular Medicine, 2005, 6
  • [6] Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities
    Pater, C
    [J]. CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2005, 6 (1):
  • [7] Efficacy and safety of pregabalin in treatment refractory patients with various neuropathic pain entities in clinical routine
    Freynhagen, R.
    Grond, S.
    Schuepfer, G.
    Hagebeuker, A.
    Schmelz, M.
    Ziegler, D.
    Von Giesen, H. -J.
    Junker, U.
    Wagner, K. J.
    Konrad, C.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (12) : 1989 - 1996
  • [8] Efficacy and safety of switching psoriatic patients to bimekizumab: new evidence from clinical trials
    Valenti, Mario
    Costanzo, Antonio
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (03) : 316 - 317
  • [9] Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors
    Di Cosimo, S
    Ferretti, G
    Papaldo, P
    Carlini, P
    Fabi, A
    Cognetti, F
    [J]. DRUGS OF TODAY, 2003, 39 (03): : 157 - 173
  • [10] Leflunomide: Efficacy and safety in clinical trials for the treatment of rheumatoid arthritis
    Schiff, MH
    Strand, V
    Oed, C
    Loew-Friedrich, I
    [J]. DRUGS OF TODAY, 2000, 36 (06): : 383 - 394
12345